Evidence map›Paper›PMID 38082346›Full record

ArticleBMC research notes2023

Hypoxia-mimetic by CoCl2 increases SLC7A5 expression in breast cancer cells in vitro.

Leonora Canhasi, Elisabet Tina, Anna Göthlin Eremo

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Molecular basis of autism spectrum disorders.Molecular biology reports · 2025
    Review
  5. Nobiletin: a potential erythropoietin receptor activator protects renal cells against hypoxia.Apoptosis : an international journal on programmed cell death · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Leonora CanhasiSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, 701 82, SE, Sweden.
Elisabet TinaSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, 701 82, SE, Sweden.
Anna Göthlin EremoSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, 701 82, SE, Sweden. anna.gothlin-eremo@regionorebrolan.se.
Örebro University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIncreased expression of the amino acid transporter solute Carrier Family 7 Member 5 (SLC7A5) has been observed in neoplastic cells during hypoxic conditions in vitro, indicating an adaptation for cell survival. To further explore this, we evaluated hypoxia-mimetic by CoCl2 as a model for hypoxia in breast cancer cell lines and the effect on SLC257A5 expression. Four different breast cancer cell lines (MCF7, T-47D, BT-474 and ZR-75-1) were exposed to 100 µM CoCl

resultsThe gene expression of VEGF, a marker of hypoxia, was significantly elevated in all four cell lines compared to the control (p < 0.0001), indicating that CoCl

Indexed as

Breast NeoplasmsLarge Neutral Amino Acid-Transporter 1Cell HypoxiaCobaltFemaleHumansHypoxiaMCF-7 CellsCobaltcobaltous chlorideLarge Neutral Amino Acid-Transporter 1CoCl2Endocrine Breast cancerHypoxiaLAT1SLC7A5

Identifiers

PMID38082346
PMCPMC10714522
OpenAlexW4389573502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.